- Home
- CBU vs VKTX Comparison
CBU vs VKTX Comparison
Compare CBU & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBU
- VKTX
- Stock Information
- Founded
- CBU 1866
- VKTX 2012
- Country
- CBU United States
- VKTX United States
- Employees
- CBU N/A
- VKTX N/A
- Industry
- CBU Major Banks
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- CBU Finance
- VKTX Health Care
- Exchange
- CBU Nasdaq
- VKTX Nasdaq
- Market Cap
- CBU 3.0B
- VKTX 3.4B
- IPO Year
- CBU N/A
- VKTX 2015
- Fundamental
- Price
- CBU $56.72
- VKTX $25.65
- Analyst Decision
- CBU Buy
- VKTX Strong Buy
- Analyst Count
- CBU 3
- VKTX 11
- Target Price
- CBU $71.00
- VKTX $95.18
- AVG Volume (30 Days)
- CBU 253.8K
- VKTX 4.0M
- Earning Date
- CBU 04-29-2025
- VKTX 04-23-2025
- Dividend Yield
- CBU 3.24%
- VKTX N/A
- EPS Growth
- CBU 40.41
- VKTX N/A
- EPS
- CBU 3.44
- VKTX N/A
- Revenue
- CBU $723,530,000.00
- VKTX N/A
- Revenue This Year
- CBU $14.73
- VKTX N/A
- Revenue Next Year
- CBU $8.81
- VKTX N/A
- P/E Ratio
- CBU $16.50
- VKTX N/A
- Revenue Growth
- CBU 12.93
- VKTX N/A
- 52 Week Low
- CBU $41.50
- VKTX $24.41
- 52 Week High
- CBU $73.39
- VKTX $82.00
- Technical
- Relative Strength Index (RSI)
- CBU 35.23
- VKTX 37.65
- Support Level
- CBU $56.39
- VKTX $25.80
- Resistance Level
- CBU $59.10
- VKTX $29.60
- Average True Range (ATR)
- CBU 1.28
- VKTX 1.69
- MACD
- CBU 0.19
- VKTX -0.17
- Stochastic Oscillator
- CBU 23.72
- VKTX 17.19
About CBU Community Bank System Inc.
Community Financial System Inc is a diversified financial services company providing a broad array of banking and other financial services to retail, commercial, institutional and governmental customers. The Company also offers comprehensive financial planning, trust administration and wealth management services through its Community Bank Wealth Management operating unit. It has four reportable operating business segments: Banking and Corporate, Employee Benefit Services, Insurance Services and Wealth Management Services.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.